Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 7

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 15
Chunk 7
---
onomy Extension Calculation Linkbase Document

    X

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document

    X

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document

    X

    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document

    X

    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document) and contained in Exhibit 101)

    X

† Confidential treatment has been granted for a portion of this exhibit.

+ Certain confidential information contained in this exhibit has been omitted because it is both (i) not material and (ii) the type that the Registrant treats as private or confidential.

* Indicates management contract or compensatory plan or arrangement.

(1)The certifications attached as Exhibit 32.1 accompany this Annual Report on Form 10-K pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.